Service advice and planning
38 results
Applied filters
Marketed CAR-T therapy
13 February 2026This document outlines key areas where Chief Pharmacists should focus pharmaceutical expertise prior to an organisation implementing CAR-T therapy.
In-vivo non-GMO gene therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmacy expertise prior to an organisation implementing in-vivo non-genetically modified organism gene therapies.
Somatic cell therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmaceutical expertise prior to an organisation implementing somatic cell therapy product.
Use of PGDs by trainee registered healthcare professionals
12 February 2026Advice on the use of Patient Group Directions by registered healthcare professionals who are undertaking training and/or competency assessment
Product design considerations for optimising ATMP implementation
11 February 2026This guidance provides advice for ATMP developers, highlighting implementation challenges faced by the NHS and suggesting design consideration to minimise them.
Performing preparation risk assessments for ATMPs
11 February 2026Preparation risk assessment tools for cell and tissue-based advanced therapy medicinal products (ATMPs) and in-vivo gene therapies.
Managing out of specification ATMPs
11 February 2026This document clarifies the regulatory expectation regarding OOS ATMPs and advises hospitals on governance in the event of an OOS ATMP being offered for use.
Validation master plans
18 November 2025A validation master plan summarises all planned validation activities in a medicines preparation or manufacturing unit.
Registration of Quality Controllers: Medical Gas Pipeline Systems
18 November 2025Quality controllers who test NHS medical gas pipelines must be suitably trained and experienced
Radiopharmaceuticals: advice for chief pharmacists
18 November 2025The safe use of radiopharmaceuticals falls within the remit of chief pharmacists.